Evidence map›Paper›PMID 39505759›Full record

ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2025

Longitudinal validation of the PROMIS-16 in a sample of adults in the United States with back pain.

Anthony Rodriguez, Chengbo Zeng, Ron D Hays, Patricia M Herman, Maria O Edelen

Abstract readValidation Study
In one paragraph

Article in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A direct comparison of the measurement properties of the PROMIS-16 and EQ-5D-5L in the U.S. general population.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anthony RodriguezRAND Corporation, Behavioral and Policy Sciences, 20 Park Plaza #910, Boston, MA, USA. anthonyr@rand.org.ORCID http://orcid.org/0000-0001-9485-0003
Chengbo ZengPatient Reported Outcomes, Value and Experience (PROVE) Center, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.
Ron D HaysDivision of General Internal Medicine and Health Services Research, UCLA Department of Medicine, Los Angeles, CA, USA.
Patricia M HermanRAND Corporation, Behavioral and Policy Sciences, 1776 Main Street, Santa Monica, CA, USA.
Maria O EdelenRAND Corporation, Behavioral and Policy Sciences, 20 Park Plaza #910, Boston, MA, USA.

Funding

Measuring Chronic Pain ImpactR01AT010402 · NCCIH · RAND CORPORATION · PI HAYS, RONALD DALE, HERMAN, PATRICIA M · 2020 to 2023
$2.5M
NCCIH NIH HHS R01 AT010402
6 · The paper itself

Abstract

purposeThis longitudinal study evaluates whether the Patient-Reported Outcomes Measurement and Information System (PROMIS)-16 domains capture average change over time comparable to the PROMIS-29 + 2 and have similar associations with change in overall health rating and two disability indices.

methodsData were collected using Amazon's Mechanical Turk at baseline, 3 months, and 6 months among individuals reporting chronic low back pain. The analytic sample includes respondents who completed baseline and at least one follow-up assessment (N = 1137). We estimated latent growth models for eight PROMIS domains and compared growth parameters between the PROMIS-16 and PROMIS 29 + 2 with a z-test. Additionally, for each domain, random intercept and slope scores for individuals were computed for the PROMIS-29 + 2 and PROMIS-16 and correlated to estimate concordance. Using growth parameters for physical function and pain interference, we predicted average change in the Oswestry Disability Index (ODI), Roland Morris Disability Questionnaire (RMDQ), the overall health rating, and compared regression coefficients between the PROMIS-16 and PROMIS 29 + 2.

resultsAll growth models fit the data well. Intercept and slope parameters were statistically comparable (p's > 0.05) in magnitude across all domains between the PROMIS-16 and PROMIS-29 + 2. Correlations between random intercept and slope scores for individuals across domains were high. Additionally, the regression coefficients between slopes for pain interference and physical function and ODI, RMDQ, and overall health rating were statistically comparable (p's > 0.05) between the PROMIS-16 and PROMIS 29 + 2.

conclusionResults provide between-level support for the longitudinal and predictive validity of the PROMIS-16. Similar average baseline scores and changes over time were observed between PROMIS-16 and PROMIS-29 + 2. Further, average change estimates comparably predicted average change in distal outcomes. This work provides evidence supporting the utility of the PROMIS-16 as a viable, short-profile option for use in clinical and research settings.

Indexed as

Back PainLow Back PainPatient Reported Outcome MeasuresAdultAgedDisability EvaluationFemaleHumansLongitudinal StudiesMaleMiddle AgedPain MeasurementPsychometricsQuality of LifeReproducibility of ResultsSurveys and QuestionnairesHealth-related quality of lifePatient-reported outcomesPROMIS-16PROMIS-29 + 2Short form validation

Identifiers

PMID39505759
PMCPMC11802292

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.